| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $93.1M | +75.1% |
| SG&A Expense | $20.4M | -4.6% |
| Operating Income | -$113.5M | -52.2% |
| Pre-tax Income | -$127.4M | -83.0% |
| Income Tax | $58K | +5.5% |
| Net Income | -$127.4M | -83.0% |
| EPS (Basic) | -$3.19 | -30.7% |
| EPS (Diluted) | -$3.19 | -30.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.4M | +162.0% |
| Short-term Investments | $247.7M | +452.1% |
| Current Assets | $348.8M | +335.4% |
| Total Assets | $349.8M | +335.4% |
| Current Liabilities | $16.5M | +332.1% |
| Total Liabilities | $17.3M | +342.9% |
| Stockholders' Equity | $332.5M | +335.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.7M | -33.0% |
| Capital Expenditures | $196K | — |
| Investing Cash Flow | -$247.0M | -540.9% |
| Financing Cash Flow | $360.8M | +1318.8% |
| Free Cash Flow | -$94.9M | — |